Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not ...
HER-2 targeted antibody-drug conjugate monotherapy has demonstrated efficacy in the post-chemotherapy setting for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback